📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigoâ„¢) in breast cancer patients with BONe metastases: CARBON trial results. (2022)

First Author: Winter M
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jbo.2022.100442

PubMed Identifier: 35800293

Publication URI: http://europepmc.org/abstract/MED/35800293

Type: Journal Article/Review

Volume: 35

Parent Publication: Journal of bone oncology

ISSN: 2212-1366